妊娠期糖尿病亚型的代谢组学与遗传结构
本研究基于HAPO研究,在约28周行OGTT,将GDM分为胰岛素缺乏型和胰岛素抵抗型。代谢组分析纳入3463人(576例GDM),基因组分析纳入8067人(1323例GDM)。两亚型代谢物关联不同,GCKR与MTNR1B变异与胰岛素抵抗型GDM全基因组显著关联,与胰岛素缺乏型无显著关联。
要点
- 胰岛素缺乏型GDM独有33种空腹代谢物关联,包括22种中长链酰基肉碱。
- 胰岛素抵抗型GDM独有23种代谢物关联,包括支链氨基酸及其代谢物。
- GCKR与MTNR1B变异与胰岛素抵抗型GDM全基因组显著关联,与胰岛素缺乏型无显著关联。
核心结论
- 生理性GDM亚型在代谢组和遗传结构上存在差异,这些差异可能 contribute to 亚型相关的不良妊娠结局,但需在更多队列中重复验证。
研究设计与样本
- 横断面研究,纳入HAPO研究中约28周妊娠行OGTT的参与者,回顾性依据IADPSG/WHO标准定义GDM并分为胰岛素缺乏型(胰岛素分泌<第25百分位且胰岛素敏感性保留)或胰岛素抵抗型(胰岛素敏感性<第25百分位且胰岛素分泌保留)。
- 代谢组分析纳入3463人(576例GDM),对空腹和1小时血清样本进行分析;全基因组基因型数据纳入8067人(1323例GDM)。
主要发现
- 校正协变量后,33种空腹代谢物(包括22种中长链酰基肉碱)独与胰岛素缺乏型GDM相关;23种代谢物(包括支链氨基酸及其代谢物)独与胰岛素抵抗型GDM相关;甘油和2-羟基丁酸两种代谢物与两亚型关联方向相同。
- 全基因组关联研究中,MTNR1B变异(rs10830963,p=3.43×10-18,OR 1.55)和GCKR变异(rs1260326,p=5.17×10-13,OR 1.43)与GDM相关。
- GCKR变异(rs1260326,p=1.36×10-13,OR 1.60)和MTNR1B变异(rs10830963,p=1.22×10-9,OR 1.49)与胰岛素抵抗型GDM全基因组显著关联;与胰岛素缺乏型GDM无显著关联。
- GCKR lead SNP rs1260326与25种空腹代谢物中的8种及41种1小时代谢物中的10种(这些代谢物与胰岛素抵抗型GDM相关)的水平相关。
局限性
- 原文结论指出这些发现需要在更多队列中重复验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Physiological gestational diabetes mellitus (GDM) subtypes that may confer different risks for adverse pregnancy outcomes have been defined. The aim of this study was to characterise the metabolome and genetic architecture of GDM subtypes to address the hypothesis that they differ between GDM subtypes. METHODS: This was a cross-sectional study of participants in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study who underwent an OGTT at approximately 28 weeks' gestation. GDM was defined retrospectively using International Association of Diabetes and Pregnancy Study Groups/WHO criteria, and classified as insulin-deficient GDM (insulin secretion <25th percentile with preserved insulin sensitivity) or insulin-resistant GDM (insulin sensitivity <25th percentile with preserved insulin secretion). Metabolomic analyses were performed on fasting and 1 h serum samples in 3463 individuals (576 with GDM). Genome-wide genotype data were obtained for 8067 individuals (1323 with GDM). RESULTS: Regression analyses demonstrated striking differences between the metabolomes for insulin-deficient or insulin-resistant GDM compared to those with normal glucose tolerance. After adjustment for covariates, 33 fasting metabolites, including 22 medium- and long-chain acylcarnitines, were uniquely associated with insulin-deficient GDM; 23 metabolites, including the branched-chain amino acids and their metabolites, were uniquely associated with insulin-resistant GDM; two metabolites (glycerol and 2-hydroxybutyrate) were associated with the same direction of association with both subtypes. Subtype differences were also observed 1 h after a glucose load. In genome-wide association studies, variants within MTNR1B (rs10830963, p=3.43×10-18, OR 1.55) and GCKR (rs1260326, p=5.17×10-13, OR 1.43) were associated with GDM. Variants in GCKR (rs1260326, p=1.36×10-13, OR 1.60) and MTNR1B (rs10830963, p=1.22×10-9, OR 1.49) demonstrated genome-wide significant association with insulin-resistant GDM; there were no significant associations with insulin-deficient GDM. The lead SNP in GCKR, rs1260326, was associated with the levels of eight of the 25 fasting metabolites that were associated with insulin-resistant GDM and ten of 41 1 h metabolites that were associated with insulin-resistant GDM. CONCLUSIONS/INTERPRETATION: This study demonstrates that physiological GDM subtypes differ in their metabolome and genetic architecture. These findings require replication in additional cohorts, but suggest that these differences may contribute to subtype-related adverse pregnancy outcomes.
引用
- Lee K, Kuang A, Bain JR, et al. Metabolomic and genetic architecture of gestational diabetes subtypes. Diabetologia. 2024. PMID: 38367033. doi:10.1007/s00125-024-06110-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。